Hongkai Shang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hongkai Shang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Bin Yang
Department of Radiology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
1 shared publication Hongjiang Zhao
The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China
1 shared publication- Hongjiang Zhao
The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China
1 shared publication - Huan Shi
The Fourth Clinical School of Medicine, Zhejiang Chinese Medical University, Hangzhou First People’s Hospital, Hangzhou, China
1 shared publication - Jie Yu
The Fourth Clinical School of Medicine, Zhejiang Chinese Medical University, Hangzhou First People’s Hospital, Hangzhou, China
1 shared publication - Jing Qian
Department of Gynecology, Affiliated Hangzhou First People’s Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang Province, China
1 shared publication
Latest Publications
- Open Access
- 17 June 2025
- Published by Springer Nature in Lasers in Medical Science
- Vol. 40 (1) , 1-10
A comparative study of 5-aminolevulinic acid photodynamic therapy and loop electrosurgical excision procedure in the treatment of cervical high grade squamous intraepithelial lesions
Purpose To compare the efficacy and safety of 5-Aminolevulinic Acid Photodynamic Therapy (5-ALA-PDT) and Loop Electrosurgical Excision Procedure (LEEP) in the treatment of cervical high grade squamous intraepithelial lesions (HSIL). Methods The data of 116 patients with pathologically diagnosed cervical HSIL in Hangzhou First People’s Hospital from January 2020 to June 2023 were retrospectively analyzed. According to the treatment methods, they were divided into 5-ALA-PDT group (50 cases) and LEEP group (66 cases). The patients were followed up at 3 months, 6 months, and 12 months after treatment. The clinical data of the two groups were compared. Results There were no significant differences in baseline data between the two groups of patients (P > 0.05). At 12-month follow-up the complete remission (CR) rate of LEEP group and 5-ALA-PDT group was 93.94% (62/66) and 86.00% (43/50) (P = 0.260), respectively. The HPV clearance rate of LEEP group and 5-ALA-PDT group was 66.67% (44/66) and 80.00% (40/50) (P = 0.112), respectively. Multivariate analysis revealed that endocervical canal involvement was a significant risk factor for 5-ALA-PDT failure (OR = 27.35, 95% CI: 3.512–43.390, P = 0.012) and persistent HPV infection (OR = 8.013, 95% CI: 2.045–36.901, P = 0.011). In terms of adverse reactions, most of the reactions in 5-ALA-PDT group were mild local reactions that could be relieved within one week. The proportion of bleeding and cervical scar formation was higher in patients in the LEEP group (P < 0.05). Conclusion 5-ALA-PDT and LEEP exhibit potential similarity in efficacy in the treatment of cervical HSIL, but the former has milder adverse reactions. The involvement of the endocervical canal is a significant risk factor for both 5-ALA-PDT failure and persistent HPV infection.
- 17 June 2025
- Published by Springer Nature in Lasers in Medical Science
- Vol. 40 (1) , 1-10
Open AccessA comparative study of 5-aminolevulinic acid photodynamic therapy and loop electrosurgical excision procedure in the treatment of cervical high grade squamous intraepithelial lesions
Purpose To compare the efficacy and safety of 5-Aminolevulinic Acid Photodynamic Therapy (5-ALA-PDT) and Loop Electrosurgical Excision Procedure (LEEP) in the treatment of cervical high grade squamous intraepithelial lesions (HSIL). Methods The data of 116 patients with pathologically diagnosed cervical HSIL in Hangzhou First People’s Hospital from January 2020 to June 2023 were retrospectively analyzed. According to the treatment methods, they were divided into 5-ALA-PDT group (50 cases) and LEEP group (66 cases). The patients were followed up at 3 months, 6 months, and 12 months after treatment. The clinical data of the two groups were compared. Results There were no significant differences in baseline data between the two groups of patients (P > 0.05). At 12-month follow-up the complete remission (CR) rate of LEEP group and 5-ALA-PDT group was 93.94% (62/66) and 86.00% (43/50) (P = 0.260), respectively. The HPV clearance rate of LEEP group and 5-ALA-PDT group was 66.67% (44/66) and 80.00% (40/50) (P = 0.112), respectively. Multivariate analysis revealed that endocervical canal involvement was a significant risk factor for 5-ALA-PDT failure (OR = 27.35, 95% CI: 3.512–43.390, P = 0.012) and persistent HPV infection (OR = 8.013, 95% CI: 2.045–36.901, P = 0.011). In terms of adverse reactions, most of the reactions in 5-ALA-PDT group were mild local reactions that could be relieved within one week. The proportion of bleeding and cervical scar formation was higher in patients in the LEEP group (P < 0.05). Conclusion 5-ALA-PDT and LEEP exhibit potential similarity in efficacy in the treatment of cervical HSIL, but the former has milder adverse reactions. The involvement of the endocervical canal is a significant risk factor for both 5-ALA-PDT failure and persistent HPV infection.
- Open Access
- 20 December 2022
- Published by Taylor & Francis in All Life
- Vol. 15 (1) , 1330-1339
The role of ferroptosis in the side effects of dexamethasone
As a regulatory cell death caused by iron-dependent lipid peroxidation, ferroptosis is very important in the healthy development or disease progression of various organisms. Dexamethasone is a glucocorticoid with vigorous immunosuppressive activity and anti-inflammatory effects. On the other hand, it can cause some side effects under long-term or high-dose administration, including secondary osteoporosis and osteonecrosis, which are associated with the elevated autophagy and involvement of ferroptosis. Autophagy, an intracellular degradation system, plays a crucial role in ferroptosis. It has been increasingly proved that ferroptosis is potentially related to the dexamethasone-induced side effects, in which autophagy may be involved. However, the regulatory mechanism of ferroptosis in the dexamethasone-induced side effects is unclear. This review summarizes the molecular mechanisms of ferroptosis, the dexamethasone-induced side effects, and the potential relationships between ferroptosis and dexamethasone-induced side effects, aiming to provide novel insight into the interplay between them.
- 20 December 2022
- Published by Taylor & Francis in All Life
- Vol. 15 (1) , 1330-1339
Open AccessThe role of ferroptosis in the side effects of dexamethasone
As a regulatory cell death caused by iron-dependent lipid peroxidation, ferroptosis is very important in the healthy development or disease progression of various organisms. Dexamethasone is a glucocorticoid with vigorous immunosuppressive activity and anti-inflammatory effects. On the other hand, it can cause some side effects under long-term or high-dose administration, including secondary osteoporosis and osteonecrosis, which are associated with the elevated autophagy and involvement of ferroptosis. Autophagy, an intracellular degradation system, plays a crucial role in ferroptosis. It has been increasingly proved that ferroptosis is potentially related to the dexamethasone-induced side effects, in which autophagy may be involved. However, the regulatory mechanism of ferroptosis in the dexamethasone-induced side effects is unclear. This review summarizes the molecular mechanisms of ferroptosis, the dexamethasone-induced side effects, and the potential relationships between ferroptosis and dexamethasone-induced side effects, aiming to provide novel insight into the interplay between them.
- Open Access
- 29 July 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (30) , e29670
Midgut malrotation presenting with hyperemesis gravidarum: A case report
Rationale: Midgut malrotation is a rare congenital abnormality resulting from failure of complete intestinal rotation and subsequent fixation during early fetal development. There appeared to be no obvious symptoms in most patients, and a few patients may exhibit symptoms similar to hyperemesis gravidarum, such as nausea and vomiting. Here, we present a case of midgut malrotation presenting as hyperemesis gravidarum. Patient concerns: A 27-year-old woman with an intrauterine pregnancy of 27 + 6 weeks complained of severe nausea and vomiting for 2 weeks. Diagnosis: Magnetic resonance imaging showed obvious dilatation in the proximal part of the duodenum and gastric cavity and the absence of a duodenal path dorsal to the superior mesenteric artery, which was diagnosed as midgut malrotation. Interventions: Considering that the patient’s vital signs were stable, without manifestation of peritonitis or the risks of surgery to the fetus, conservative treatment was adopted. Unfortunately, the fetus developed severe hydrocephalus at 32 weeks. The patient and her family decided to abandon the fetus, and a mid-trimester-induced abortion was performed. Outcomes: The related symptoms completely disappeared after delivery, and the relevant examination after discharge also confirmed the presence of midgut malrotation without gastrointestinal discomfort within 1 year after delivery. Lessons: Midgut malrotation can be considered as a differential diagnosis of hyperemesis gravidarum. Conservative treatment under close monitoring is desirable in pregnant women diagnosed with midgut malrotation.
- 29 July 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (30) , e29670
Open AccessMidgut malrotation presenting with hyperemesis gravidarum: A case report
Rationale: Midgut malrotation is a rare congenital abnormality resulting from failure of complete intestinal rotation and subsequent fixation during early fetal development. There appeared to be no obvious symptoms in most patients, and a few patients may exhibit symptoms similar to hyperemesis gravidarum, such as nausea and vomiting. Here, we present a case of midgut malrotation presenting as hyperemesis gravidarum. Patient concerns: A 27-year-old woman with an intrauterine pregnancy of 27 + 6 weeks complained of severe nausea and vomiting for 2 weeks. Diagnosis: Magnetic resonance imaging showed obvious dilatation in the proximal part of the duodenum and gastric cavity and the absence of a duodenal path dorsal to the superior mesenteric artery, which was diagnosed as midgut malrotation. Interventions: Considering that the patient’s vital signs were stable, without manifestation of peritonitis or the risks of surgery to the fetus, conservative treatment was adopted. Unfortunately, the fetus developed severe hydrocephalus at 32 weeks. The patient and her family decided to abandon the fetus, and a mid-trimester-induced abortion was performed. Outcomes: The related symptoms completely disappeared after delivery, and the relevant examination after discharge also confirmed the presence of midgut malrotation without gastrointestinal discomfort within 1 year after delivery. Lessons: Midgut malrotation can be considered as a differential diagnosis of hyperemesis gravidarum. Conservative treatment under close monitoring is desirable in pregnant women diagnosed with midgut malrotation.